#12088 on the rich list of 14,644 insiders
J. Kevin Buchi
Director at Amneal Pharmaceuticals; Director at Benitec Biopharma. Based in Bridgewater, New Jersey.
$6.5M
in disclosed stock, −$145K (−2.20%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 12088th of 14,644
- Companies held
- 2
- Largest holding
- AMRX, 93.4% of total
- Latest SEC filing
- Sep 17, 2026
What the $6.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals AMRX Class A Common Stock | Through Trust | 113,944 | $21.39 | $2.4M | 37.7% | Form 4, Sep 17, 2026 |
| Amneal Pharmaceuticals AMRX Class A Common Stock | Through Trust | 93,499 | $21.39 | $2.0M | 30.9% | Form 4, Sep 11, 2026 |
| Amneal Pharmaceuticals AMRX Class A Common Stock | Directly | 75,077 | $21.39 | $1.6M | 24.8% | Form 4, Sep 17, 2026 |
| Benitec Biopharma BNTC Common Stock | Directly | 52,097 | $8.14 | $424K | 6.6% | Form 4, Jun 29, 2026 |
Share counts are the amounts J. Kevin Buchi reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 12085 | Richard Blackshaw EVP, Brand President, Crocs. Broomfield, CO | $6.5M |
| 12086 | Julie L. Gerberding EVP, Chief Patient Officer, Merck & Co.. Kenilworth, NJ | $6.5M |
| 12087 | Jay Stout Chief Technology Officer, Immunovant. Durham, NC | $6.5M |
| 12088 | J. Kevin Buchi Director, Amneal Pharmaceuticals. Bridgewater, NJ | $6.5M |
| 12089 | Cormac Stuart Chief Accounting Officer, AerCap Holdings | $6.5M |
| 12090 | Tahnil R. Davis Chief Accounting Officer & EVP, The Trade Desk. Ventura, CA | $6.5M |
| 12091 | Terrell Kirk Crews II EVP, Chief Risk Officer, NextEra Energy. Juno Beach, FL | $6.5M |
Other Amneal Pharmaceuticals insiders
All AMRX insiders- Tushar Patel$1.31B10% owner. #207 overall
- Chintu Patel$627MCo-CEO. #404 overall
- Dipan Patel$575MInsider. #441 overall
- Chirag K. Patel$553MPresident & Co-CEO. #460 overall
- Gautam Patel$41.2MDirector. #2838 overall
- Paul M. Meister$17.8MDirector. #4499 overall
Questions
How much stock does J. Kevin Buchi own?
J. Kevin Buchi holds $6,467,172 in listed stock based on SEC filings and current prices, mostly Amneal Pharmaceuticals (AMRX). That ranks 12088th on the Stock Rich List.
Is this J. Kevin Buchi's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.